Status: Closed 4/15/04
Eligibility:

* Measurable disease defined by examination, radiographs or ultrasound
* No cytotoxic therapy within 3 weeks of trial initiation
* Prednisone or NSAID therapy permitted if introduced at least 3 weeks before trial initiation
* Must receive at least 4 months of treatment with antiangiogenic therapy (described above)

Antiangiogenic therapy for dogs with any measurable cancer following relapse on antiangiogenic therapy
Trial Support: Study patients receive vascular targeted therapy at no charge. Medical examination and diagnostic tests needed to measure response are the responsibility of the owner. All cases must be evaluated and treated through the Animal Cancer Institute primary clinic site a Friendship Hospital for Animals, Washington, DC.